{"id":4203,"date":"2026-02-17T15:38:09","date_gmt":"2026-02-17T14:38:09","guid":{"rendered":"https:\/\/www.phinc-group.com\/?page_id=4203"},"modified":"2026-05-26T11:20:09","modified_gmt":"2026-05-26T09:20:09","slug":"vision","status":"publish","type":"page","link":"https:\/\/www.phinc-group.com\/en\/vision\/","title":{"rendered":"Our vision"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"4203\" class=\"elementor elementor-4203\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-37051e4 e-con-full e-flex e-con e-parent\" data-id=\"37051e4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-725b23e elementor-widget elementor-widget-html\" data-id=\"725b23e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>\r\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Cormorant+Garamond:ital,wght@0,300;0,400;1,300;1,400&family=Poppins:ital,wght@0,200;0,300;0,400;1,200;1,300&display=swap');\r\n\r\n.pvision-wrap {\r\n  --navy:    #00005f;\r\n  --pink:    #d94b9f;\r\n  --navy-06: rgba(0,0,95,0.05);\r\n  --navy-12: rgba(0,0,95,0.09);\r\n  --navy-20: rgba(0,0,95,0.14);\r\n  --pink-06: rgba(217,75,159,0.06);\r\n  --pink-15: rgba(217,75,159,0.13);\r\n  --pink-20: rgba(217,75,159,0.18);\r\n  --white:   #ffffff;\r\n  --off:     #f8f8fb;\r\n  --text:    #15152e;\r\n  --muted:   #72728e;\r\n  --line:    rgba(0,0,95,0.09);\r\n  font-family: 'Poppins', sans-serif;\r\n  font-weight: 200;\r\n  color: var(--text);\r\n  line-height: 1.65;\r\n  background: var(--off);\r\n}\r\n\r\n\/* \u2500\u2500 HERO \u2500\u2500 *\/\r\n.pvision-hero {\r\n  padding: 5rem 5vw 4rem;\r\n  max-width: 820px;\r\n  margin: 0 auto;\r\n  text-align: center;\r\n}\r\n.pvision-eyebrow {\r\n  display: inline-block;\r\n  font-size: 0.65rem;\r\n  font-weight: 400;\r\n  letter-spacing: 0.26em;\r\n  text-transform: uppercase;\r\n  color: var(--pink);\r\n  border: 1px solid var(--pink-20);\r\n  border-radius: 2rem;\r\n  padding: 0.3rem 1rem;\r\n  margin-bottom: 1.4rem;\r\n}\r\n.pvision-hero h1 {\r\n  font-family: 'Cormorant Garamond', Georgia, serif;\r\n  font-size: clamp(2.2rem, 4.5vw, 3.6rem);\r\n  font-weight: 300;\r\n  color: var(--navy);\r\n  line-height: 1.1;\r\n  letter-spacing: -0.01em;\r\n  margin-bottom: 1.4rem;\r\n}\r\n.pvision-hero h1 em {\r\n  font-style: italic;\r\n  color: var(--pink);\r\n}\r\n.pvision-hero-sub {\r\n  font-size: 0.88rem;\r\n  font-weight: 210;\r\n  color: #666;\r\n  line-height: 1.9;\r\n  margin-bottom: 2rem;\r\n  max-width: 620px;\r\n  margin-left: auto;\r\n  margin-right: auto;\r\n}\r\n\r\n\r\n\r\n\/* \u2500\u2500 DIVIDER \u2500\u2500 *\/\r\n.pvision-divider {\r\n  display: flex;\r\n  align-items: center;\r\n  gap: 1rem;\r\n  max-width: 1000px;\r\n  margin: 0 auto 0;\r\n  padding: 0 5vw;\r\n}\r\n.pvision-divider::before,\r\n.pvision-divider::after { content: ''; flex: 1; height: 1px; background: var(--line); }\r\n.pvision-pip { width: 5px; height: 5px; border-radius: 50%; background: var(--pink); opacity: 0.5; }\r\n\r\n\/* \u2500\u2500 SECTION LABEL \u2500\u2500 *\/\r\n.pvision-section-label {\r\n  max-width: 1000px;\r\n  margin: 3.5rem auto 1.4rem;\r\n  padding: 0 5vw;\r\n  display: flex;\r\n  align-items: center;\r\n  gap: 1rem;\r\n}\r\n.pvision-section-label::after { content: ''; flex: 1; height: 1px; background: var(--line); }\r\n.pvision-section-label span {\r\n  font-size: 0.62rem;\r\n  font-weight: 400;\r\n  letter-spacing: 0.22em;\r\n  text-transform: uppercase;\r\n  color: var(--muted);\r\n  white-space: nowrap;\r\n}\r\n\r\n\/* \u2500\u2500 SECTION INTRO \u2500\u2500 *\/\r\n.pvision-section-intro {\r\n  max-width: 1000px;\r\n  margin: 0 auto 2rem;\r\n  padding: 0 5vw;\r\n}\r\n.pvision-section-intro h2 {\r\n  font-family: 'Cormorant Garamond', Georgia, serif;\r\n  font-size: clamp(1.7rem, 3vw, 2.5rem);\r\n  font-weight: 300;\r\n  color: var(--navy);\r\n  line-height: 1.15;\r\n  margin-bottom: 0.8rem;\r\n}\r\n.pvision-section-intro h2 em { font-style: italic; color: var(--pink); }\r\n.pvision-section-intro p {\r\n  font-size: 0.88rem;\r\n  font-weight: 210;\r\n  color: #666;\r\n  line-height: 1.9;\r\n  max-width: 780px;\r\n}\r\n\r\n\/* \u2500\u2500 3 AXES GRID \u2500\u2500 *\/\r\n.pvision-axes {\r\n  max-width: 1000px;\r\n  margin: 0 auto;\r\n  padding: 0 5vw 1rem;\r\n  display: grid;\r\n  grid-template-columns: repeat(3, 1fr);\r\n  gap: 1.1rem;\r\n}\r\n.pvision-axe {\r\n  background: var(--white);\r\n  border: 1px solid var(--line);\r\n  border-radius: 14px;\r\n  padding: 1.6rem 1.5rem 1.8rem;\r\n  position: relative;\r\n  overflow: hidden;\r\n  opacity: 0;\r\n  transform: translateY(20px);\r\n  transition: opacity 0.6s ease, transform 0.6s ease, box-shadow 0.3s, border-color 0.3s;\r\n}\r\n.pvision-axe::before {\r\n  content: '';\r\n  position: absolute;\r\n  top: 0; left: 0; right: 0;\r\n  height: 3px;\r\n  background: linear-gradient(90deg, var(--navy), var(--pink));\r\n}\r\n.pvision-axe.pvision-visible { opacity: 1; transform: translateY(0); }\r\n.pvision-axe.pvision-visible:hover {\r\n  box-shadow: 0 8px 40px rgba(0,0,95,0.08);\r\n  border-color: rgba(217,75,159,0.22);\r\n  transform: translateY(-2px);\r\n}\r\n.pvision-axe-num {\r\n  font-size: 0.58rem;\r\n  font-weight: 400;\r\n  letter-spacing: 0.22em;\r\n  text-transform: uppercase;\r\n  color: var(--pink);\r\n  background: var(--pink-06);\r\n  border-radius: 2rem;\r\n  padding: 0.2rem 0.65rem;\r\n  display: inline-block;\r\n  margin-bottom: 0.85rem;\r\n}\r\n.pvision-axe h3 {\r\n  font-family: 'Cormorant Garamond', Georgia, serif;\r\n  font-size: 1.7rem;\r\n  font-weight: 300;\r\n  color: var(--navy);\r\n  line-height: 1.2;\r\n  margin-bottom: 0.65rem;\r\n}\r\n.pvision-axe p {\r\n  font-size: 0.9rem;\r\n  font-weight: 210;\r\n  color: #666;\r\n  line-height: 1.85;\r\n  margin: 0;\r\n}\r\n\r\n\/* \u2500\u2500 ACCORDION CARDS \u2500\u2500 *\/\r\n.pvision-accordion-grid {\r\n  max-width: 1000px;\r\n  margin: 0 auto;\r\n  padding: 0 5vw 1rem;\r\n  display: grid;\r\n  grid-template-columns: 1fr 1fr;\r\n  gap: 1rem;\r\n  align-items: start;\r\n}\r\n.pvision-accordion {\r\n  background: var(--white);\r\n  border: 1px solid var(--line);\r\n  border-radius: 12px;\r\n  overflow: hidden;\r\n  opacity: 0;\r\n  transform: translateY(16px);\r\n  transition: opacity 0.6s ease, transform 0.6s ease, border-color 0.3s;\r\n}\r\n.pvision-accordion.pvision-visible { opacity: 1; transform: translateY(0); }\r\n.pvision-accordion.pvision-visible:hover { border-color: rgba(217,75,159,0.22); }\r\n\r\n.pvision-accordion summary {\r\n  list-style: none;\r\n  cursor: pointer;\r\n  display: grid;\r\n  grid-template-columns: 40px 1fr 20px;\r\n  gap: 0.9rem;\r\n  align-items: center;\r\n  padding: 1rem 1.1rem;\r\n  user-select: none;\r\n}\r\n.pvision-accordion summary::-webkit-details-marker { display: none; }\r\n\r\n.pvision-acc-num {\r\n  width: 40px; height: 40px;\r\n  border-radius: 50%;\r\n  background: linear-gradient(135deg, var(--navy-06) 0%, var(--pink-06) 100%);\r\n  border: 1px solid var(--line);\r\n  display: flex;\r\n  align-items: center;\r\n  justify-content: center;\r\n  font-size: 0.72rem;\r\n  font-weight: 400;\r\n  color: var(--navy);\r\n  flex-shrink: 0;\r\n  transition: background 0.25s, border-color 0.25s;\r\n}\r\n.pvision-accordion[open] .pvision-acc-num,\r\n.pvision-accordion summary:hover .pvision-acc-num {\r\n  background: linear-gradient(135deg, var(--navy-12) 0%, var(--pink-15) 100%);\r\n  border-color: rgba(217,75,159,0.3);\r\n}\r\n\r\n.pvision-acc-title {\r\n  font-size: 0.82rem;\r\n  font-weight: 300;\r\n  color: var(--navy);\r\n  line-height: 1.3;\r\n}\r\n\r\n.pvision-acc-chevron {\r\n  width: 20px; height: 20px;\r\n  display: flex;\r\n  align-items: center;\r\n  justify-content: center;\r\n  color: var(--muted);\r\n  transition: transform 0.25s ease;\r\n}\r\n.pvision-accordion[open] .pvision-acc-chevron { transform: rotate(180deg); }\r\n\r\n.pvision-acc-body {\r\n  padding: 0 1.1rem 1.1rem 3.6rem;\r\n  font-size: 0.78rem;\r\n  font-weight: 200;\r\n  color: var(--muted);\r\n  line-height: 1.85;\r\n}\r\n\r\n\/* \u2500\u2500 QUOTE BLOCK \u2500\u2500 *\/\r\n.pvision-quote {\r\n  max-width: 1000px;\r\n  margin: 2.5rem auto 0;\r\n  padding: 0 5vw 5rem;\r\n}\r\n.pvision-quote-inner {\r\n  background: var(--white);\r\n  border: 1px solid var(--line);\r\n  border-left: 3px solid var(--pink);\r\n  border-radius: 0 12px 12px 0;\r\n  padding: 1.6rem 2rem;\r\n}\r\n.pvision-quote-inner h3 {\r\n  font-family: 'Cormorant Garamond', Georgia, serif;\r\n  font-size: 1.5rem;\r\n  font-weight: 300;\r\n  color: var(--navy);\r\n  margin-bottom: 0.6rem;\r\n}\r\n.pvision-quote-inner p {\r\n  font-size: 0.88rem;\r\n  font-weight: 200;\r\n  color: #666;\r\n  line-height: 1.9;\r\n  margin: 0;\r\n}\r\n\r\n\/* \u2500\u2500 BANNER \u2500\u2500 *\/\r\n.pvision-banner {\r\n  background: var(--navy);\r\n  padding: 4rem 5vw;\r\n}\r\n.pvision-banner-inner {\r\n  max-width: 1000px;\r\n  margin: 0 auto;\r\n  display: grid;\r\n  grid-template-columns: 1fr auto;\r\n  gap: 3rem;\r\n  align-items: center;\r\n}\r\n.pvision-banner h2 {\r\n  font-family: 'Cormorant Garamond', Georgia, serif;\r\n  font-size: clamp(1.6rem, 3vw, 2.4rem);\r\n  font-weight: 300;\r\n  color: #ffffff;\r\n  line-height: 1.15;\r\n  margin-bottom: 0.65rem;\r\n}\r\n.pvision-banner h2 em { font-style: italic; color: var(--pink); }\r\n.pvision-banner p {\r\n  font-size: 0.82rem;\r\n  font-weight: 200;\r\n  color: rgba(255,255,255,0.44);\r\n  line-height: 1.85;\r\n  margin: 0;\r\n}\r\n.pvision-banner-cta {\r\n  display: inline-flex;\r\n  align-items: center;\r\n  gap: 0.6rem;\r\n  padding: 0.75rem 1.8rem;\r\n  border: 1px solid rgba(255,255,255,0.35);\r\n  border-radius: 2rem;\r\n  color: #fff;\r\n  font-size: 0.78rem;\r\n  font-weight: 300;\r\n  letter-spacing: 0.08em;\r\n  text-transform: uppercase;\r\n  text-decoration: none;\r\n  white-space: nowrap;\r\n  transition: border-color 0.2s, background 0.2s, transform 0.2s;\r\n}\r\n.pvision-banner-cta:hover { border-color: rgba(255,255,255,0.7); background: rgba(255,255,255,0.07); transform: translateY(-1px); }\r\n\r\n\/* \u2500\u2500 RESPONSIVE \u2500\u2500 *\/\r\n@media (max-width: 860px) {\r\n  .pvision-hero { padding: 3rem 5vw 2.5rem; }\r\n  .pvision-axes { grid-template-columns: 1fr; }\r\n  .pvision-accordion-grid { grid-template-columns: 1fr; }\r\n  .pvision-banner-inner { grid-template-columns: 1fr; gap: 1.5rem; }\r\n}\r\n<\/style>\r\n\r\n<div class=\"pvision-wrap\">\r\n\r\n<!-- HERO -->\r\n<div class=\"pvision-hero\">\r\n  <div class=\"pvision-eyebrow\">Notre Vision<\/div>\r\n    <h1>La mod\u00e9lisation &amp; simulation,<br><em>essentielles<\/em> \u00e0 chaque<br>d\u00e9veloppement clinique<\/h1>\r\n    <p class=\"pvision-hero-sub\">Les bouleversements du secteur pharmaceutique et l'\u00e9mergence des techniques de mod\u00e9lisation et de simulation appliqu\u00e9es ont profond\u00e9ment transform\u00e9 l'organisation de la R&amp;D. Plus que jamais, nous sommes un partenaire privil\u00e9gi\u00e9 et fiable pour les biotechs qui souhaitent int\u00e9grer efficacement la pharmacom\u00e9trie et la mod\u00e9lisation \u00e0 leur d\u00e9veloppement de m\u00e9dicaments.<\/p>\r\n    \r\n<\/div>\r\n\r\n\r\n<!-- AXES -->\r\n<div class=\"pvision-section-label\"><span>Notre singularit\u00e9<\/span><\/div>\r\n<div class=\"pvision-section-intro\">\r\n  <h2>Une strat\u00e9gie construite<br>autour de <em>3 axes<\/em> compl\u00e9mentaires<\/h2>\r\n  <p>Aujourd'hui, PhinC Development est un acteur cl\u00e9 en Europe pour l'int\u00e9gration des approches de mod\u00e9lisation &amp; simulation tout au long du d\u00e9veloppement d'un candidat m\u00e9dicament. Notre force repose sur trois piliers qui s\u00e9curisent les d\u00e9cisions et acc\u00e9l\u00e8rent l'ex\u00e9cution.<\/p>\r\n<\/div>\r\n\r\n<div class=\"pvision-axes\">\r\n  <div class=\"pvision-axe\">\r\n    <span class=\"pvision-axe-num\">Axe 01<\/span>\r\n    <h3>Mod\u00e8les avanc\u00e9s &amp; simulations robustes<\/h3>\r\n    <p>Nous d\u00e9veloppons les mod\u00e8les les plus pertinents pour exploiter l'ensemble des donn\u00e9es disponibles \u00e0 chaque phase et produire des rapports solides, align\u00e9s avec les attentes des agences (EMA et FDA).<\/p>\r\n  <\/div>\r\n  <div class=\"pvision-axe\">\r\n    <span class=\"pvision-axe-num\">Axe 02<\/span>\r\n    <h3>Conseil &amp; accompagnement sur-mesure<\/h3>\r\n    <p>PhinC accompagne ses partenaires d\u00e8s les premi\u00e8res phases, avec des conseils \u00e9clair\u00e9s et une strat\u00e9gie de mod\u00e9lisation pharmacom\u00e9trique adapt\u00e9e \u00e0 chaque programme de d\u00e9veloppement.<\/p>\r\n  <\/div>\r\n  <div class=\"pvision-axe\">\r\n    <span class=\"pvision-axe-num\">Axe 03<\/span>\r\n    <h3>Agilit\u00e9 &amp; culture biotech<\/h3>\r\n    <p>Notre organisation et nos modes de collaboration s'ajustent aux contraintes des biotechs. Nous intervenons tr\u00e8s t\u00f4t sur la strat\u00e9gie afin d'expliquer la valeur ajout\u00e9e de la mod\u00e9lisation.<\/p>\r\n  <\/div>\r\n<\/div>\r\n\r\n<!-- INNOVATION -->\r\n<div class=\"pvision-section-label\"><span>Innovation<\/span><\/div>\r\n<div class=\"pvision-section-intro\">\r\n  <h2>Des mod\u00e8les pr\u00e9dictifs pour lever<br>les <em>obstacles cl\u00e9s<\/em> du d\u00e9veloppement<\/h2>\r\n  <p>Face aux obstacles et d\u00e9fis majeurs du d\u00e9veloppement, PhinC mobilise son expertise en pharmacom\u00e9trie, pharmacocin\u00e9tique, pharmacologie et biostatistiques pour construire des mod\u00e8les pr\u00e9dictifs innovants. Ces outils donnent aux biotechs un avantage d\u00e9cisif en permettant de r\u00e9pondre \u00e0 une multitude de d\u00e9fis.<\/p>\r\n<\/div>\r\n\r\n<div class=\"pvision-accordion-grid\">\r\n\r\n  <details class=\"pvision-accordion\">\r\n    <summary>\r\n      <div class=\"pvision-acc-num\">01<\/div>\r\n      <span class=\"pvision-acc-title\">Complexit\u00e9 croissante des protocoles<\/span>\r\n      <div class=\"pvision-acc-chevron\">\r\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M6 9l6 6 6-6\"\/><\/svg>\r\n      <\/div>\r\n    <\/summary>\r\n    <div class=\"pvision-acc-body\">\u00c9valuer plusieurs param\u00e8tres simultan\u00e9ment, isoler des effets sp\u00e9cifiques et quantifier l'impact pharmacologique seul ou en interaction.<\/div>\r\n  <\/details>\r\n\r\n  <details class=\"pvision-accordion\">\r\n    <summary>\r\n      <div class=\"pvision-acc-num\">02<\/div>\r\n      <span class=\"pvision-acc-title\">Multiplication des sources de donn\u00e9es<\/span>\r\n      <div class=\"pvision-acc-chevron\">\r\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M6 9l6 6 6-6\"\/><\/svg>\r\n      <\/div>\r\n    <\/summary>\r\n    <div class=\"pvision-acc-body\">Int\u00e9grer litt\u00e9rature, in vitro, in vivo et donn\u00e9es humaines, puis enrichir le mod\u00e8le au fil des r\u00e9sultats obtenus pendant le d\u00e9veloppement.<\/div>\r\n  <\/details>\r\n\r\n  <details class=\"pvision-accordion\">\r\n    <summary>\r\n      <div class=\"pvision-acc-num\">03<\/div>\r\n      <span class=\"pvision-acc-title\">Gestion des risques<\/span>\r\n      <div class=\"pvision-acc-chevron\">\r\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M6 9l6 6 6-6\"\/><\/svg>\r\n      <\/div>\r\n    <\/summary>\r\n    <div class=\"pvision-acc-body\">Anticiper des risques de toxicit\u00e9 (cardiaque, r\u00e9nale, h\u00e9patique) via l'exposition et des biomarqueurs (ex. troponine, QT), et aider au choix de la premi\u00e8re dose chez l'humain gr\u00e2ce \u00e0 l'extrapolation inter-esp\u00e8ces.<\/div>\r\n  <\/details>\r\n\r\n  <details class=\"pvision-accordion\">\r\n    <summary>\r\n      <div class=\"pvision-acc-num\">04<\/div>\r\n      <span class=\"pvision-acc-title\">Exigences \u00e9thiques &amp; r\u00e9duction des co\u00fbts<\/span>\r\n      <div class=\"pvision-acc-chevron\">\r\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M6 9l6 6 6-6\"\/><\/svg>\r\n      <\/div>\r\n    <\/summary>\r\n    <div class=\"pvision-acc-body\">Pr\u00e9dire l'exposition syst\u00e9mique ou au site d'action avec une marge d'erreur ma\u00eetris\u00e9e pour r\u00e9duire le nombre de doses test\u00e9es et optimiser le nombre d'animaux, de volontaires ou d'\u00e9chantillons.<\/div>\r\n  <\/details>\r\n\r\n  <details class=\"pvision-accordion\">\r\n    <summary>\r\n      <div class=\"pvision-acc-num\">05<\/div>\r\n      <span class=\"pvision-acc-title\">\u00ab Derisking \u00bb du programme<\/span>\r\n      <div class=\"pvision-acc-chevron\">\r\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M6 9l6 6 6-6\"\/><\/svg>\r\n      <\/div>\r\n    <\/summary>\r\n    <div class=\"pvision-acc-body\">Anticiper la marge th\u00e9rapeutique (toxicit\u00e9 vs activit\u00e9), \u00e9viter d'engager un d\u00e9veloppement trop risqu\u00e9, et explorer t\u00f4t les risques d'interaction, d'effet nourriture, ou de populations sp\u00e9cifiques.<\/div>\r\n  <\/details>\r\n\r\n<\/div>\r\n\r\n<!-- QUOTE -->\r\n<div class=\"pvision-quote\">\r\n  <div class=\"pvision-quote-inner\">\r\n    <h3>Notre objectif<\/h3>\r\n    <p>En pratique, nos approches contribuent \u00e0 optimiser les designs d'\u00e9tudes, \u00e0 r\u00e9duire les it\u00e9rations inutiles, et \u00e0 s\u00e9curiser les choix critiques \u2014 dose, sch\u00e9ma posologique, fen\u00eatres th\u00e9rapeutiques, interactions, variabilit\u00e9.<\/p>\r\n  <\/div>\r\n<\/div>\r\n\r\n<!-- BANNER -->\r\n<section class=\"pvision-banner\">\r\n  <div class=\"pvision-banner-inner\">\r\n    <div>\r\n      <h2>Acc\u00e9l\u00e9rez vos d\u00e9cisions<br>avec la <em>mod\u00e9lisation<\/em><\/h2>\r\n      <p>Dites-nous o\u00f9 vous en \u00eates \u2014 Lead Optimization, pr\u00e9clinique, FIH, phases II\/III, strat\u00e9gie DDI, QT\/QTc\u2026 Nous vous aidons \u00e0 cadrer la meilleure approche et les livrables attendus.<\/p>\r\n    <\/div>\r\n    <a class=\"pvision-banner-cta\" href=\"\/contact\">Planifier un \u00e9change<\/a>\r\n  <\/div>\r\n<\/section>\r\n\r\n<\/div>\r\n\r\n<script>\r\n(function(){\r\n  var els = document.querySelectorAll('.pvision-axe, .pvision-accordion');\r\n  if (!els.length) return;\r\n  var io = new IntersectionObserver(function(entries){\r\n    entries.forEach(function(e, i){\r\n      if(e.isIntersecting){\r\n        setTimeout(function(){ e.target.classList.add('pvision-visible'); }, i * 80);\r\n        io.unobserve(e.target);\r\n      }\r\n    });\r\n  }, { threshold: 0.08 });\r\n  els.forEach(function(el){ io.observe(el); });\r\n})();\r\n<\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Notre Vision La mod\u00e9lisation &amp; simulation,essentielles \u00e0 chaqued\u00e9veloppement clinique Les bouleversements du secteur pharmaceutique et l&rsquo;\u00e9mergence des techniques de mod\u00e9lisation et de simulation appliqu\u00e9es ont profond\u00e9ment transform\u00e9 l&rsquo;organisation de la R&amp;D. Plus que jamais, nous sommes un partenaire privil\u00e9gi\u00e9 et fiable pour les biotechs qui souhaitent int\u00e9grer efficacement la pharmacom\u00e9trie et la mod\u00e9lisation \u00e0 leur [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4203","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Notre vision - PhinC Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.phinc-group.com\/en\/vision\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre vision - PhinC Group\" \/>\n<meta property=\"og:description\" content=\"Notre Vision La mod\u00e9lisation &amp; simulation,essentielles \u00e0 chaqued\u00e9veloppement clinique Les bouleversements du secteur pharmaceutique et l&rsquo;\u00e9mergence des techniques de mod\u00e9lisation et de simulation appliqu\u00e9es ont profond\u00e9ment transform\u00e9 l&rsquo;organisation de la R&amp;D. Plus que jamais, nous sommes un partenaire privil\u00e9gi\u00e9 et fiable pour les biotechs qui souhaitent int\u00e9grer efficacement la pharmacom\u00e9trie et la mod\u00e9lisation \u00e0 leur [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.phinc-group.com\/en\/vision\/\" \/>\n<meta property=\"og:site_name\" content=\"PhinC Group\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-26T09:20:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.phinc-group.com\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-16-janv.-2026-10_02_20-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/vision\\\/\",\"url\":\"https:\\\/\\\/www.phinc-group.com\\\/vision\\\/\",\"name\":\"Notre vision - PhinC Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-02-17T14:38:09+00:00\",\"dateModified\":\"2026-05-26T09:20:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/vision\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.phinc-group.com\\\/vision\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/vision\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.phinc-group.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notre vision\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/\",\"name\":\"PhinC Group\",\"description\":\"Quantitative Pharmacology Solutions &amp; Modeling\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#organization\",\"name\":\"PhinC Group\",\"url\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.phinc-group.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Icone-PhinC-New_white-600px.jpg\",\"contentUrl\":\"https:\\\/\\\/www.phinc-group.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Icone-PhinC-New_white-600px.jpg\",\"width\":600,\"height\":600,\"caption\":\"PhinC Group\"},\"image\":{\"@id\":\"https:\\\/\\\/www.phinc-group.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre vision - PhinC Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.phinc-group.com\/en\/vision\/","og_locale":"en_US","og_type":"article","og_title":"Notre vision - PhinC Group","og_description":"Notre Vision La mod\u00e9lisation &amp; simulation,essentielles \u00e0 chaqued\u00e9veloppement clinique Les bouleversements du secteur pharmaceutique et l&rsquo;\u00e9mergence des techniques de mod\u00e9lisation et de simulation appliqu\u00e9es ont profond\u00e9ment transform\u00e9 l&rsquo;organisation de la R&amp;D. Plus que jamais, nous sommes un partenaire privil\u00e9gi\u00e9 et fiable pour les biotechs qui souhaitent int\u00e9grer efficacement la pharmacom\u00e9trie et la mod\u00e9lisation \u00e0 leur [&hellip;]","og_url":"https:\/\/www.phinc-group.com\/en\/vision\/","og_site_name":"PhinC Group","article_modified_time":"2026-05-26T09:20:09+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.phinc-group.com\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-16-janv.-2026-10_02_20-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.phinc-group.com\/vision\/","url":"https:\/\/www.phinc-group.com\/vision\/","name":"Notre vision - PhinC Group","isPartOf":{"@id":"https:\/\/www.phinc-group.com\/fr\/#website"},"datePublished":"2026-02-17T14:38:09+00:00","dateModified":"2026-05-26T09:20:09+00:00","breadcrumb":{"@id":"https:\/\/www.phinc-group.com\/vision\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.phinc-group.com\/vision\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.phinc-group.com\/vision\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.phinc-group.com\/"},{"@type":"ListItem","position":2,"name":"Notre vision"}]},{"@type":"WebSite","@id":"https:\/\/www.phinc-group.com\/fr\/#website","url":"https:\/\/www.phinc-group.com\/fr\/","name":"PhinC Group","description":"Quantitative Pharmacology Solutions &amp; Modeling","publisher":{"@id":"https:\/\/www.phinc-group.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.phinc-group.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.phinc-group.com\/fr\/#organization","name":"PhinC Group","url":"https:\/\/www.phinc-group.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.phinc-group.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.phinc-group.com\/wp-content\/uploads\/2025\/01\/Icone-PhinC-New_white-600px.jpg","contentUrl":"https:\/\/www.phinc-group.com\/wp-content\/uploads\/2025\/01\/Icone-PhinC-New_white-600px.jpg","width":600,"height":600,"caption":"PhinC Group"},"image":{"@id":"https:\/\/www.phinc-group.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/pages\/4203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/comments?post=4203"}],"version-history":[{"count":22,"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/pages\/4203\/revisions"}],"predecessor-version":[{"id":5006,"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/pages\/4203\/revisions\/5006"}],"wp:attachment":[{"href":"https:\/\/www.phinc-group.com\/en\/wp-json\/wp\/v2\/media?parent=4203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}